癌症相关的SPOP突变体的系统性表征揭示了新的和可重编程的降解性活动
Alana G Caldwell1, Harshil Parmar2, Xiaokang Jin2
1Interdisciplinary Biological Sciences Graduate Program, Northwestern University, Evanston, Illinois 60208, United States.
bioRxiv : the preprint server for biology
|December 3, 2025
概括
前列腺癌中斑点型POZ蛋白 (SPOP) 突变显示了基质依赖的功能损失. 这些SPOP变体可以重新用于向的蛋白质降解疗法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 斑点型POZ蛋白 (SPOP) 是Cullin3-RING酶 (CRL3) 复合体的一个关键基质适配器.
- 在前列腺癌中观察到反复发生的SPOP突变,特别是基质结合域中的F102C和F133L.
- 这些特定的SPOP突变的精确生物化学影响在很大程度上仍然未被描述.
研究的目的:
- 为了阐明SPOP突变F102C和F133L的生物化学后果.
- 为了研究突变的SPOP蛋白质的基质特异性和降解活性.
- 探索SPOP突变体在向蛋白质降解中的治疗潜力.
主要方法:
- 使用定量蛋白质组学来分析蛋白质降解.
- 进行了功能性测试,以评估SPOP突变体对核篮蛋白 (NUP153,TPR) 的降解活性.
- 细胞系统的设计是为了评估SPOP突变体在向蛋白质降解 (TPD) 中的实用性.
主要成果:
- 与SPOP-F102C不同,SPOP-F133L保留了对NUP153和TPR的降解活性,这表明基质依赖功能丧失.
- SPOP-F133L通过CRL依赖的翻译后机制调节部分p53的下调,这表明一种新的新基质.
- SPOP-F102C和SPOP-F133L都证明了在工程细胞系统中支持向蛋白质降解的有效性.
结论:
- 该研究确定了SPOP突变F102C和F133L的特定降解能力.
- 结果揭示了SPOP突变中的基质依赖功能变化.
- 突变的SPOP蛋白质为开发突变选择性E3链酶提供了机会,用于针对性蛋白质降解的治疗应用.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K


